Life Sciences Tools & Services
Danaher's Q2 FY2026 revenue grew 5.5% YoY to $6.265B and net income rose 56.8% to $870M (EPS $1.23), driven by core sales growth and the absence of a prior-year $432M trade-name impairment, while the company closed its ~$9.8B acquisition of Masimo on June 10, 2026, adding significant long-term debt and goodwill.
Key risk: Masimo Acquisition Integration and Related Costs
The $9.8 billion Masimo acquisition, closed June 10, 2026, generated 175 basis points of unfavorable operating margin impact in Q2 from fair value inventory adjustments, significant transaction costs, and pre-acquisition share-based/change-in-control payments; successful integration and realization of anticipated benefits are not guaranteed.
Other Life Sciences Tools & Services companies